{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T01:22:44Z","timestamp":1789521764918,"version":"build-2803163510"},"reference-count":55,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2019,8,28]],"date-time":"2019-08-28T00:00:00Z","timestamp":1566950400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0221477","type":"journal-article","created":{"date-parts":[[2019,8,28]],"date-time":"2019-08-28T17:41:06Z","timestamp":1567014066000},"page":"e0221477","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":14,"title":["Oncostatin M reduces atherosclerosis development in APOE*3Leiden.CETP mice and is associated with increased survival probability in humans"],"prefix":"10.1371","volume":"14","author":[{"given":"Danielle van","family":"Keulen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9657-871X","authenticated-orcid":true,"given":"Marianne G.","family":"Pouwer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valur","family":"Emilsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ljubica Perisic","family":"Matic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elsbet J.","family":"Pieterman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulf","family":"Hedin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5696-0084","authenticated-orcid":true,"given":"Vilmundur","family":"Gudnason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lori L.","family":"Jennings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Holmstr\u00f8m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boye Schnack","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard","family":"Pasterkamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan H. N.","family":"Lindeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0010-5286","authenticated-orcid":true,"given":"Alain J.","family":"van Gool","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarten D.","family":"Sollewijn Gelpke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7206-1596","authenticated-orcid":true,"given":"Hans M. G.","family":"Princen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8061-6483","authenticated-orcid":true,"given":"Dennie","family":"Tempel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,8,28]]},"reference":[{"key":"pone.0221477.ref001","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.cytogfr.2015.04.003","article-title":"Cytokines in atherosclerosis: Key players in all stages of disease and promising therapeutic targets","volume":"26","author":"DP Ramji","year":"2015","journal-title":"Cytokine Growth Factor Rev"},{"key":"pone.0221477.ref002","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.plipres.2011.04.002","article-title":"Cytokines, macrophage lipid metabolism and foam cells: Implications for cardiovascular disease therapy","volume":"50","author":"JE McLaren","year":"2011","journal-title":"Prog Lipid Res"},{"key":"pone.0221477.ref003","doi-asserted-by":"crossref","first-page":"317503","DOI":"10.1155\/2013\/317503","article-title":"Oncostatin M and TLR-4 ligand synergize to induce MCP-1, IL-6, and VEGF in human aortic adventitial fibroblasts and smooth muscle cells","volume":"2013","author":"D Schnittker","year":"2013","journal-title":"Mediators Inflamm"},{"key":"pone.0221477.ref004","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1002\/jcb.25088","article-title":"Oncostatin M Promotes Osteoblastic Differentiation of Human Vascular Smooth Muscle Cells Through JAK3-STAT3 Pathway","volume":"116","author":"Y Kakutani","year":"2015","journal-title":"J Cell Biochem"},{"key":"pone.0221477.ref005","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1161\/01.RES.0000026421.61398.F2","article-title":"Induction of bone-type alkaline phosphatase in human vascular smooth muscle cells: roles of tumor necrosis factor-alpha and oncostatin M derived from macrophages","volume":"91","author":"A Shioi","year":"2002","journal-title":"Circ Res"},{"key":"pone.0221477.ref006","doi-asserted-by":"crossref","first-page":"5244","DOI":"10.4049\/jimmunol.169.9.5244","article-title":"Secretion of oncostatin M by infiltrating neutrophils: regulation of IL-6 and chemokine expression in human mesothelial cells","volume":"169","author":"SM Hurst","year":"2002","journal-title":"J Immunol"},{"key":"pone.0221477.ref007","doi-asserted-by":"crossref","first-page":"6215","DOI":"10.1016\/S0021-9258(17)37590-7","article-title":"Oncostatin M and leukemia inhibitory factor trigger overlapping and different signals through partially shared receptor complexes","volume":"269","author":"B Thoma","year":"1994","journal-title":"J Biol Chem"},{"key":"pone.0221477.ref008","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.4049\/jimmunol.147.7.2175","article-title":"Regulation of IL-6 expression by oncostatin M","volume":"147","author":"TJ Brown","year":"1991","journal-title":"J Immunol"},{"key":"pone.0221477.ref009","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1172\/JCI119508","article-title":"Oncostatin M is a proinflammatory mediator. In vivo effects correlate with endothelial cell expression of inflammatory cytokines and adhesion molecules","volume":"100","author":"V Modur","year":"1997","journal-title":"J Clin Invest"},{"issue":"10","key":"pone.0221477.ref010","doi-asserted-by":"crossref","first-page":"e0204911","DOI":"10.1371\/journal.pone.0204911","article-title":"Inflammatory cytokine oncostatin M induces endothelial activation in macro-and microvascular endothelial cells and in APOE*3Leiden.CETP mice","volume":"13","author":"D Van Keulen","year":"2018","journal-title":"PLOS ONE"},{"key":"pone.0221477.ref011","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.neulet.2008.06.030","article-title":"Oncostatin M induces functional and structural impairment of blood\u2013brain barriers comprised of rat brain capillary endothelial cells","volume":"441","author":"F Takata","year":"2008","journal-title":"Neurosci Lett"},{"key":"pone.0221477.ref012","doi-asserted-by":"crossref","DOI":"10.1161\/01.ATV.19.8.1835","article-title":"Oncostatin M Induces Angiogenesis In Vitro and In Vivo","volume":"19","author":"M Vasse","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"pone.0221477.ref013","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.atherosclerosis.2011.02.003","article-title":"Oncostatin M is expressed in atherosclerotic lesions: a role for Oncostatin M in the pathogenesis of atherosclerosis","volume":"216","author":"A Albasanz-Puig","year":"2011","journal-title":"Atherosclerosis. Elsevier"},{"key":"pone.0221477.ref014","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1194\/jlr.M074112","article-title":"Oncostatin M receptor \u03b2 deficiency attenuates atherogenesis by inhibiting JAK2\/STAT3 signaling in macrophages","volume":"58","author":"X Zhang","year":"2017","journal-title":"J Lipid Res"},{"key":"pone.0221477.ref015","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa1612790","article-title":"Genetic and Pharmacologic Inactivation of ANGPTL3 and Cardiovascular Disease","volume":"377","author":"FE Dewey","year":"2017","journal-title":"N Engl J Med"},{"key":"pone.0221477.ref016","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/joim.12448","article-title":"Gene expression signatures, pathways and networks in carotid atherosclerosis","volume":"279","author":"L Perisic","year":"2016","journal-title":"J Intern Med"},{"key":"pone.0221477.ref017","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.atherosclerosis.2009.11.016","article-title":"The natural history of aortic atherosclerosis: A systematic histopathological evaluation of the peri-renal region","volume":"210","author":"RA van Dijk","year":"2010","journal-title":"Atherosclerosis"},{"key":"pone.0221477.ref018","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.omtm.2018.05.003","article-title":"Integrated Human Evaluation of the Lysophosphatidic Acid Pathway as a Novel Therapeutic Target in Atherosclerosis","volume":"10","author":"S Aldi","year":"2018","journal-title":"Mol Ther\u2014Methods Clin Dev"},{"key":"pone.0221477.ref019","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1002\/jcb.25606","article-title":"Fully Automated RNAscope In Situ Hybridization Assays for Formalin-Fixed Paraffin-Embedded Cells and Tissues","volume":"117","author":"CM Anderson","year":"2016","journal-title":"J Cell Biochem"},{"key":"pone.0221477.ref020","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1093\/aje\/kwk115","article-title":"Age, Gene\/Environment Susceptibility-Reykjavik Study: multidisciplinary applied phenomics","volume":"165","author":"TB Harris","year":"2007","journal-title":"Am J Epidemiol"},{"key":"pone.0221477.ref021","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1126\/science.aaq1327","article-title":"Co-regulatory networks of human serum proteins link genetics to disease","volume":"361","author":"V Emilsson","year":"2018","journal-title":"Science"},{"key":"pone.0221477.ref022","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1194\/jlr.M051326","article-title":"Alirocumab inhibits atherosclerosis, improves the plaque morphology, and enhances the effects of a statin","volume":"55","author":"S K\u00fchnast","year":"2014","journal-title":"J Lipid Res"},{"key":"pone.0221477.ref023","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/HJH.0b013e32834ddd8e","article-title":"Aliskiren inhibits atherosclerosis development and improves plaque stability in APOE*3Leiden.CETP transgenic mice with or without treatment with atorvastatin","volume":"30","author":"S K\u00fchnast","year":"2012","journal-title":"J Hypertens"},{"key":"pone.0221477.ref024","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1161\/01.ATV.20.5.1177","article-title":"Natural History and Histological Classification of Atherosclerotic Lesions: An Update","volume":"20","author":"HC Stary","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"pone.0221477.ref025","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1093\/eurheartj\/ehx260","article-title":"The AT04A vaccine against proprotein convertase subtilisin\/kexin type 9 reduces total cholesterol, vascular inflammation, and atherosclerosis in APOE*3Leiden.CETP mice","volume":"38","author":"C Landlinger","year":"2017","journal-title":"Eur Heart J"},{"key":"pone.0221477.ref026","doi-asserted-by":"crossref","first-page":"e0175336","DOI":"10.1371\/journal.pone.0175336","article-title":"Impact of human monocyte and macrophage polarization on NLR expression and NLRP3 inflammasome activationeditor","volume":"12","author":"F Awad","year":"2017","journal-title":"PLoS One"},{"key":"pone.0221477.ref027","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1161\/CIRCRESAHA.111.253377","article-title":"NR4A1 (Nur77) deletion polarizes macrophages toward an inflammatory phenotype and increases atherosclerosis","volume":"110","author":"RN Hanna","year":"2012","journal-title":"Circ Res"},{"key":"pone.0221477.ref028","unstructured":"Therneau TM, Crowson CS, Atkinson Jan EJ. Adjusted Survival Curves [Internet]. Available: https:\/\/cran.r-project.org\/web\/packages\/survival\/vignettes\/adjcurve.pdf"},{"key":"pone.0221477.ref029","doi-asserted-by":"crossref","first-page":"H1962","DOI":"10.1152\/ajpheart.01366.2006","article-title":"The inflammatory cytokine oncostatin M induces PAI-1 in human vascular smooth muscle cells in vitro via PI 3-kinase and ERK1\/2-dependent pathways","volume":"293","author":"S Demyanets","year":"2007","journal-title":"Am J Physiol Circ Physiol"},{"key":"pone.0221477.ref030","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.ajpath.2014.11.008","article-title":"Oncostatin M, an Inflammatory Cytokine Produced by Macrophages, Supports Intramembranous Bone Healing in a Mouse Model of Tibia Injury","volume":"185","author":"P Guihard","year":"2015","journal-title":"Am J Pathol"},{"key":"pone.0221477.ref031","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/apha.12466","article-title":"Vascular smooth muscle cell in atherosclerosis","volume":"214","author":"DA Chistiakov","year":"2015","journal-title":"Acta Physiol. Wiley\/Blackwell"},{"key":"pone.0221477.ref032","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0021-9150(01)00696-7","article-title":"Reduced expression of endothelial cell markers after 1 year treatment with simvastatin and atorvastatin in patients with coronary heart disease","volume":"162","author":"I Seljeflot","year":"2002","journal-title":"Atherosclerosis"},{"key":"pone.0221477.ref033","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1161\/ATVBAHA.108.179705","article-title":"Inflammation in atherosclerosis","volume":"32","author":"P. Libby","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"pone.0221477.ref034","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.cytogfr.2008.08.003","article-title":"Structures and biological functions of IL-31 and IL-31 receptors","volume":"19","author":"Q Zhang","year":"2008","journal-title":"Cytokine Growth Factor Rev"},{"key":"pone.0221477.ref035","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1161\/ATVBAHA.114.304650","article-title":"Nonclassical patrolling monocyte function in the vasculature","volume":"35","author":"G Thomas","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"pone.0221477.ref036","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/nm.4307","article-title":"Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor\u2013neutralizing therapy in patients with inflammatory bowel disease","volume":"23","author":"NR West","year":"2017","journal-title":"Nat Med"},{"issue":"3","key":"pone.0221477.ref037","first-page":"iii75","article-title":"Oncostatin M in the anti-inflammatory response","volume":"60","author":"AF Wahl","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"pone.0221477.ref038","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1111\/j.1582-4934.2011.01412.x","article-title":"Oncostatin M decreases interleukin-1 \u03b2 secretion by human synovial fibroblasts and attenuates an acute inflammatory reaction in vivo","volume":"16","author":"A Dumas","year":"2012","journal-title":"J Cell Mol Med"},{"key":"pone.0221477.ref039","doi-asserted-by":"crossref","first-page":"21861","DOI":"10.1074\/jbc.M113.461905","article-title":"Lack of oncostatin M receptor \u03b2 leads to adipose tissue inflammation and insulin resistance by switching macrophage phenotype","volume":"288","author":"T Komori","year":"2013","journal-title":"J Biol Chem"},{"key":"pone.0221477.ref040","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.cardiores.2005.01.001","article-title":"Tumor necrosis factor-a promotes atherosclerotic lesion progression in APOE*3-leiden transgenic mice","volume":"66","author":"L Boesten","year":"2005","journal-title":"Cardiovasc Res"},{"key":"pone.0221477.ref041","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1161\/01.ATV.0000064374.15232.C3","article-title":"Lack of interleukin-1beta decreases the severity of atherosclerosis in ApoE-deficient mice","volume":"23","author":"H Kirii","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"pone.0221477.ref042","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1136\/annrheumdis-2016-209784","article-title":"Relationship between exposure to tumour necrosis factor inhibitor therapy and incidence and severity of myocardial infarction in patients with rheumatoid arthritis","volume":"76","author":"ASL Low","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"pone.0221477.ref043","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease","volume":"377","author":"PM Ridker","year":"2017","journal-title":"N Engl J Med"},{"key":"pone.0221477.ref044","first-page":"317905","article-title":"OSM Enhances Angiogenesis and Improves Cardiac Function after Myocardial Infarction","volume":"2015","author":"X Zhang","year":"2015","journal-title":"Biomed Res Int"},{"key":"pone.0221477.ref045","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/cvr\/cvn081","article-title":"Vascular repair by endothelial progenitor cells","volume":"78","author":"A Zampetaki","year":"2008","journal-title":"Cardiovasc Res"},{"key":"pone.0221477.ref046","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1172\/JCI119821","article-title":"Retrograde inflammatory signaling from neutrophils to endothelial cells by soluble interleukin-6 receptor alpha","volume":"100","author":"V Modur","year":"1997","journal-title":"J Clin Invest"},{"key":"pone.0221477.ref047","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.2741\/4055","article-title":"Endothelial progenitor cells in atherosclerosis","volume":"17","author":"F Du","year":"2012","journal-title":"Front Biosci"},{"key":"pone.0221477.ref048","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1161\/ATVBAHA.108.179739","article-title":"Concept of vulnerable\/unstable plaque","volume":"30","author":"AV Finn","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"pone.0221477.ref049","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1530\/ERC-11-0326","article-title":"Oncostatin M suppresses oestrogen receptor-\u03b1 expression and is associated with poor outcome in human breast cancer","volume":"19","author":"NR West","year":"2012","journal-title":"Endocr Relat Cancer"},{"key":"pone.0221477.ref050","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1172\/JCI118532","article-title":"Modulation of very low density lipoprotein production and clearance contributes to age- and gender- dependent hyperlipoproteinemia in apolipoprotein E3-Leiden transgenic mice","volume":"97","author":"BJ van Vlijmen","year":"1996","journal-title":"J Clin Invest"},{"key":"pone.0221477.ref051","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ebiom.2017.08.019","article-title":"Low Very low-Density Lipoprotein Cholesterol but High Very low-Density Lipoprotein Receptor mRNA Expression in Peripheral White Blood Cells: An Atherogenic Phenotype for Atherosclerosis in a Community-Based Population","volume":"25","author":"F Zhao","year":"2017","journal-title":"EBioMedicine"},{"key":"pone.0221477.ref052","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.stem.2011.08.013","article-title":"Oncostatin M Is a Major Mediator of Cardiomyocyte Dedifferentiation and Remodeling","volume":"9","author":"T Kubin","year":"2011","journal-title":"Cell Stem Cell"},{"key":"pone.0221477.ref053","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/hep.20086","article-title":"Hepatocyte proliferation and tissue remodeling is impaired after liver injury in oncostatin M receptor knockout mice","volume":"39","author":"K Nakamura","year":"2004","journal-title":"Hepatology"},{"key":"pone.0221477.ref054","doi-asserted-by":"crossref","first-page":"R132","DOI":"10.1186\/ar4312","article-title":"Safety, tolerability, pharmacokinetics and pharmacodynamics of an anti- oncostatin M monoclonal antibody in rheumatoid arthritis: results from phase II randomized, placebo-controlled trials","volume":"15","author":"EH Choy","year":"2013","journal-title":"Arthritis Res Ther. BioMed Central"},{"key":"pone.0221477.ref055","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/nm.4338","article-title":"A role for oncostatin M in inflammatory bowel disease","volume":"23","author":"WM Kim","year":"2017","journal-title":"Nat Med"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0221477","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T15:41:02Z","timestamp":1695138062000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0221477"}},"subtitle":[],"editor":[{"given":"Andrea","family":"Cignarella","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,8,28]]},"references-count":55,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2019,8,28]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0221477","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,28]]}}}